Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Vladislav Sandler Ph.D. | Co-Founder, CEO & Director | 493.82k | -- | 1965 |
| Ms. Alexis M. Sandler J.D. | Independent Co-Founder & Non-Executive Director | 74.63k | -- | 1976 |
| Dr. Koen Van Besien M.D., Ph.D. | Clinical Advisor & Medical Director | -- | -- | -- |
Hemogenyx Pharmaceuticals Plc
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 17
Description
Hemogenyx Pharmaceuticals Plc, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood cancer. The company's lead product candidate is the HEMO-CAR-T therapy for the treatment and potential cure for relapsed and/or refractory acute myeloid leukemia. It also develops chimeric bait receptor to treat COVID-19 virus, as well as to treat brain cancers and/or certain neurodegenerative diseases; and CDX bi-specific antibody which eliminates hematopoietic stem cells/hematopoietic progenitors in a patient using bi-specific antibodies; and cell therapy products for bone marrow/hematopoietic stem cell transplantation. Hemogenyx Pharmaceuticals Plc was incorporated in 2013 and is headquartered in London, the United Kingdom.
Corporate Governance
Upcoming Events
April 22, 2025 at 10:59 AM UTC - April 28, 2025 at 12:00 PM UTC
Hemogenyx Pharmaceuticals Plc Earnings Date
Recent Events
Recent Events Information Not Available